Chronic treatment with reserpine and adrenocortical activation

Area of Science:

• Neuroendocrinology
• Pharmacology
• Stress Physiology

Background:

• Reserpine is known to deplete catecholamines, including norepinephrine (NE), a key neurotransmitter involved in stress response.
• Adrenocortical function, regulated by the hypothalamic-pituitary-adrenal (HPA) axis, is sensitive to central nervous system catecholamine levels.
• Understanding the long-term effects of reserpine on NE and HPA axis regulation is crucial for elucidating stress response mechanisms.

Purpose of the Study:

• To investigate the impact of chronic reserpine administration on hypothalamic norepinephrine levels and adrenocortical function in rats.
• To explore the role of norepinephrine synthesis and availability in modulating the HPA axis response following reserpine treatment.
• To determine if impaired adrenocortical activation after reserpine is linked to altered norepinephrine dynamics.

Main Methods:

• Rats received daily intraperitoneal injections of reserpine for nine days.
• Norepinephrine (NE) levels in the hypothalamus were measured.
• Tyrosine hydroxylase (TH) activity in the brain stem was assessed.
• Adrenocortical activation was provoked using alpha-methyl-para-tyrosine (chi-MpT) and exogenous ACTH.

Main Results:

• Chronic reserpine treatment significantly depleted hypothalamic NE but increased brain stem TH activity, indicating enhanced NE synthesis.
• While initial adrenocortical activation occurred, function returned to baseline by day 5.
• Administration of chi-MpT in reserpine-treated rats caused further NE depletion and adrenocortical activation, suggesting a functional NE pool's role.
• Exogenous ACTH elicited a normal response, indicating the adrenal cortex remained responsive.

Conclusions:

• The disappearance of sustained adrenocortical activation after prolonged reserpine treatment is attributed to the stimulated formation of a limited, functional pool of norepinephrine.
• This functional NE pool appears critical for the tonic inhibition of corticotropin-releasing hormone (CRH) and ACTH secretion.
• These findings highlight the complex interplay between catecholamine depletion, synthesis, and HPA axis regulation under chronic drug treatment.